Published in Glycoconj J on June 25, 2001
Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci U S A (2003) 2.56
Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation. Proc Natl Acad Sci U S A (2010) 1.10
Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-{beta}. FASEB J (2010) 1.05
Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology (2007) 1.05
Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process. Proc Natl Acad Sci U S A (2011) 1.03
Glycosphingolipids and mitochondria: role in apoptosis and disease. Glycoconj J (2004) 0.98
Glycosphingolipids as receptors for non-enveloped viruses. Viruses (2010) 0.98
Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I). Glycobiology (2009) 0.96
The role of glycosphingolipids in HIV signaling, entry and pathogenesis. Glycoconj J (2004) 0.92
Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. Clin Med Insights Oncol (2011) 0.92
Sodium-calcium exchanger complexed with GM1 ganglioside in nuclear membrane transfers calcium from nucleoplasm to endoplasmic reticulum. Proc Natl Acad Sci U S A (2009) 0.91
Understanding carbohydrate-carbohydrate interactions by means of glyconanotechnology. Glycoconj J (2004) 0.90
The non-canonical effect of N-acetyl-D-glucosamine kinase on the formation of neuronal dendrites. Mol Cells (2014) 0.87
High-sensitivity analysis of glycosphingolipids by matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight imaging mass spectrometry on transfer membranes. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.86
PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism. Protein Sci (2011) 0.85
Sphingolipid regulation of ezrin, radixin, and moesin proteins family: implications for cell dynamics. Biochim Biophys Acta (2013) 0.85
GM3 and cancer. Glycoconj J (2015) 0.83
Mutation for nonsyndromic mental retardation in the trans-2-enoyl-CoA reductase TER gene involved in fatty acid elongation impairs the enzyme activity and stability, leading to change in sphingolipid profile. J Biol Chem (2013) 0.83
The ganglioside GM3 is associated with cisplatin-induced apoptosis in human colon cancer cells. PLoS One (2014) 0.82
The interplay between bioactive sphingolipids and steroid hormones. Steroids (2010) 0.81
Disialyl gangliosides enhance tumor phenotypes with differential modalities. Glycoconj J (2012) 0.81
Gangliosides are important for the preservation of the structure and organization of RBL-2H3 mast cells. J Histochem Cytochem (2009) 0.79
N-acetyl-D-glucosamine kinase interacts with dynein light-chain roadblock type 1 at Golgi outposts in neuronal dendritic branch points. Exp Mol Med (2015) 0.78
Binding of N-acetylglucosamine (GlcNAc) β1-6-branched oligosaccharide acceptors to β4-galactosyltransferase I reveals a new ligand binding mode. J Biol Chem (2012) 0.78
Neurofibromatosis-like phenotype in Drosophila caused by lack of glucosylceramide extension. Proc Natl Acad Sci U S A (2012) 0.77
N-Acetyl-D-Glucosamine Kinase Promotes the Axonal Growth of Developing Neurons. Mol Cells (2015) 0.76
Ganglioside-binding specificities of E. coli enterotoxin LT-IIc: Importance of long-chain fatty acyl ceramide. Glycobiology (2012) 0.76
N-Acetyl-D-Glucosamine Kinase Interacts with Dynein-Lis1-NudE1 Complex and Regulates Cell Division. Mol Cells (2016) 0.75
The caveolae membrane system. Annu Rev Biochem (1998) 7.54
Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A (1978) 6.51
E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci U S A (1994) 5.31
ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science (1990) 4.45
The tetraspanin superfamily: molecular facilitators. FASEB J (1997) 4.29
Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A (1995) 3.85
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res (1996) 3.73
Differentiation of a cell line of myeloid leukemia. J Cell Physiol (1969) 3.73
Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res (1989) 3.25
Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature (1978) 2.97
Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J (1983) 2.80
Antibody affinity. 3. The role of multivalance. Immunochemistry (1972) 2.74
Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem (1996) 2.58
Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell (1996) 2.53
Gal-Gal binding and hemolysin phenotypes and genotypes associated with uropathogenic Escherichia coli. N Engl J Med (1985) 2.47
Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol (2001) 2.42
A carbohydrate domain common to both sialyl Le(a) and sialyl Le(X) is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J Biol Chem (1991) 2.40
Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature (1981) 2.35
Ganglioside inhibition of fibronectin-mediated cell adhesion to collagen. Proc Natl Acad Sci U S A (1979) 2.24
Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res (1993) 2.24
Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci U S A (1985) 2.14
Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J Clin Oncol (1994) 2.10
Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci U S A (1996) 2.10
New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem (1983) 2.08
Molecular arrangements in sphingolipids. Conformation and hydrogen bonding of ceramide and their implication on membrane stability and permeability. Biochim Biophys Acta (1976) 2.06
A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci U S A (1999) 2.05
Anomeric structure of globoside and ceramide grihexoside of human erythrocytes and hamster fibroblasts. J Biol Chem (1971) 2.05
Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02
Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem (1986) 2.00
Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem (1996) 1.98
Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta (1999) 1.96
Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A (1999) 1.95
Specific interaction between Lex and Lex determinants. A possible basis for cell recognition in preimplantation embryos and in embryonal carcinoma cells. J Biol Chem (1989) 1.88
Anti-i: a cold antibody defining the Ii relationship in human red cells. Br J Haematol (1961) 1.80
Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem (1984) 1.79
Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J Biol Chem (1984) 1.70
Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J Biol Chem (1998) 1.69
A sphingolipid having a novel type of ceramide and lacto-N-fucopentaose 3. J Biol Chem (1971) 1.68
A novel glycosulfopeptide binds to P-selectin and inhibits leukocyte adhesion to P-selectin. J Biol Chem (1999) 1.68
Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Proc Natl Acad Sci U S A (1999) 1.63
A multivalent lacto-N-fucopentaose III-lysyllysine conjugate decompacts preimplantation mouse embryos, while the free oligosaccharide is ineffective. J Exp Med (1984) 1.63
A-B Hemolytic disease of the newborn; analysis of 1480 cord blood specimens, with special reference to the direct antiglobulin test and to the group O mother. Blood (1955) 1.62
Immunochemical reactions of lipids. Prog Allergy (1969) 1.61
Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell (1982) 1.59
Characterization of a blood group I-active ganglioside. Structural requirements for I and i specificities. J Biol Chem (1979) 1.58
Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun (1991) 1.57
Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci U S A (1994) 1.56
Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem (1996) 1.54
A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. J Biol Chem (1982) 1.53
A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science (1983) 1.51
Further studies on sperm-immobilizing antibody found in sera of unexplained cases of sterility in women. Am J Obstet Gynecol (1972) 1.45
An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2. J Cell Biol (1987) 1.44
Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature (1993) 1.43
Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. EMBO J (1999) 1.42
Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc Natl Acad Sci U S A (1996) 1.41
Blood group i and I activities of "lacto-N-norhexaosylceramide" and its analogues: the structural requirements for i-specificities. Biochem Biophys Res Commun (1978) 1.37
Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J Biol Chem (1984) 1.35
A revised structure for the Forssman glycolipid hapten. J Biol Chem (1971) 1.34
New insights in glycosphingolipid function: "glycosignaling domain," a cell surface assembly of glycosphingolipids with signal transducer molecules,involved in cell adhesion coupled with signaling. Glycobiology (1998) 1.34
The hapten structure of a developmentally regulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: a preliminary note. Biochem Biophys Res Commun (1981) 1.31
Three types of blood group I specificity among monoclonal anti-I autoantibodies revealed by analogues of a branched erythrocyte glycolipid. J Exp Med (1979) 1.28
Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res (1999) 1.26
A ceramide tetrasaccharide of human erythrocyte membrane reacting with anti-type XIV pneumococcal polysaccharide antiserum. Biochim Biophys Acta (1973) 1.25
Siglecs: a family of sialic-acid binding lectins. Glycobiology (1998) 1.22
Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo. Science (1981) 1.21
Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J Biol Chem (1994) 1.21
New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins. J Biol Chem (2000) 1.20
Cell adhesion, spreading, and motility of GM3-expressing cells based on glycolipid-glycolipid interaction. J Biol Chem (1991) 1.19
Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest (1992) 1.19
Glycoconjugate expression during embryogenesis and its biological significance. Bioessays (1990) 1.18
Glycopeptides bind MHC molecules and elicit specific T cell responses. J Immunol (1993) 1.18
Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain. J Biol Chem (1984) 1.17
Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res (1999) 1.16
Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells. Cancer Res (1983) 1.14
Surface carbohydrates of hamster fibroblasts. I. Chemical characterization of surface-labeled glycosphingolipids and aspecific ceramide tetrasaccharide for transformants. J Biol Chem (1975) 1.14
Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with "A-like antigen" in human cancer. Proc Natl Acad Sci U S A (1977) 1.14
Further studies on cell adhesion based on Le(x)-Le(x) interaction, with new approaches: embryoglycan aggregation of F9 teratocarcinoma cells, and adhesion of various tumour cells based on Le(x) expression. Glycoconj J (1994) 1.13
Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamide. J Immunother Emphasis Tumor Immunol (1996) 1.13
Design and synthesis of a mimetic from an antibody complementarity-determining region. Science (1991) 1.11
Le(y) antigen expression is correlated with apoptosis (programmed cell death). Glycobiology (1993) 1.11
A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. Cancer Res (2000) 1.10
Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin. Biochemistry (1996) 1.10
Possible role of ceramide in defining structure and function of membrane glycolipids. Proc Natl Acad Sci U S A (1982) 1.09
Structures of ceramide tetrasaccharides from various sources: uniqueness of rat kidney ceramide tetrasaccharide. J Lipid Res (1972) 1.09
Association of the glycolipid pattern with antigenic alterations in mouse fibroblasts transformed by murine sarcoma virus. Cancer Res (1977) 1.07
AGGLUTINABILITY OF RED CELLS BY ANTI-I IN PATIENTS WITH THALASSEMIA MAJOR AND OTHER HAEMATOLOGICAL DISORDERS. Nature (1964) 1.06
Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain. Possible regulation of Lyn by glycosphingolipid in caveolae-like domains. J Biol Chem (1997) 1.06
Isolation and characterization of glycosphingolipids with blood group H specificity from membranes of human erythrocytes. Biochemistry (1973) 1.05
On neutral fucoglycolipids having long, branched carbohydrate chains: H-active and I-active glycosphingolipids of human erythrocyte membranes. Biochemistry (1975) 1.05
Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo. Vaccine (1997) 1.05
Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev Biol (1987) 1.04
The area-code hypothesis: the immune system provides clues to understanding the genetic and molecular basis of cell recognition during development. J Supramol Struct (1977) 1.04
Gangliosides influence angiogenesis in an experimental mouse brain tumor. Cancer Res (1999) 1.04
Protective effects of sialylated oligosaccharides in immune complex-induced acute lung injury. J Exp Med (1993) 1.04
Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene (1993) 1.03
Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses. Nat Biotechnol (1999) 1.02
Membrane differentiation in human erythroid cells: unique profiles of cell surface glycoproteins expressed in erythroblasts in vitro from three ontogenic stages. Proc Natl Acad Sci U S A (1980) 1.02
Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem (2000) 1.01
Selective inhibition of cell growth and associated changes in glycolipid metabolism induced by monovalent antibodies to glycolipids. Exp Cell Res (1977) 1.01